Mein Warenkorb

CD45R

CD45R Molekülinformation

Englischer NameLeukocyte common antigenAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3Target-AliasPTPRC,T200,CD45,Protein Tyrosine Phosphatase, Receptor Type C,CD45 Antigen,L-CA,Protein Tyrosine Phosphatase, Receptor Type, C Polypeptide,Receptor-Type Tyrosine-Protein Phosphatase C,T200 Leukocyte Common Antigen,Leukocyte Common Antigen,T200 Glycoprotein,EC 3.1.3.48,CD45R,GP180,B220,LCA,LY5,Leukocyte Common Antigens,Protein Tyrosine Phosphatase Receptor Type C,EC:3.1.3.48
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Englischer NameLeukocyte common antigen
Target-AliasPTPRC,T200,CD45,Protein Tyrosine Phosphatase, Receptor Type C,CD45 Antigen,L-CA,Protein Tyrosine Phosphatase, Receptor Type, C Polypeptide,Receptor-Type Tyrosine-Protein Phosphatase C,T200 Leukocyte Common Antigen,Leukocyte Common Antigen,T200 Glycoprotein,EC 3.1.3.48,CD45R,GP180,B220,LCA,LY5,Leukocyte Common Antigens,Protein Tyrosine Phosphatase Receptor Type C,EC:3.1.3.48
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical

Produktanfrage

CD45R Molekülalias

CD45R

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Immunomodulatory progenitor cell therapy (Celixir)Phase 3 ClinicalCelixirEndomyocardial Fibrosis; Cardiomyopathies
Details
I-131-ApamistamabBC8-I-131; BC-8; 131IBC8Phase 3 ClinicalFred Hutchinson Cancer Research CenterNeoplasms, Gonadal Tissue; Lymphoma, Mantle-Cell; Sezary Syndrome; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Lymphoma; Burkitt Lymphoma; Intraocular Lymphoma; Lymphoma, T-Cell; Lymphoma, Follicular; Waldenstrom Macroglobulinemia; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Anemia, Sideroblastic; Angioimmunoblastic T-cell Lymphoma; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Mycosis Fungoides; Leukemia-Lymphoma, Adult T-Cell; Leukemia; Lymphoma, B-Cell, Marginal Zone; Lymphoma, T-Cell, Peripheral; Hematopoietic stem cell transplantation (HSCT); Neoplastic Cells, Circulating; Leukemia, Hairy Cell; Anemia, Refractory, with Excess of Blasts; Lymphoma, Large B-Cell, Diffuse; Lymphoma, B-Cell; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Hodgkin Disease; Lymphoma, Large-Cell, Immunoblastic; Lymphomatoid Granulomatosis; Lymphoma, Extranodal NK-T-Cell; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Details
At 211 MAb BC8-B10Phase 2 ClinicalFred Hutchinson Cancer Research CenterNeoplasms
Details
  • Molekülinformation
  • Produktanfrage
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns